STOCK TITAN

AVITA Medical Inc - RCEL STOCK NEWS

Welcome to our dedicated news page for AVITA Medical (Ticker: RCEL), a resource for investors and traders seeking the latest updates and insights on AVITA Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AVITA Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AVITA Medical's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.94%
Tags
conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.47%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
36.53%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.72%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
management earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.87%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.77%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.83%
Tags
none
AVITA Medical Inc

Nasdaq:RCEL

RCEL Rankings

RCEL Stock Data

412.08M
24.56M
0.66%
27.88%
2.3%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Valencia

About RCEL

avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company’s lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.